GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » JTEC Corporation (TSE:3446) » Definitions » Capex-to-Revenue

JTEC (TSE:3446) Capex-to-Revenue : 0.00 (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is JTEC Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

JTEC's Capital Expenditure for the three months ended in Mar. 2024 was 円0.00 Mil. Its Revenue for the three months ended in Mar. 2024 was 円265.84 Mil.

Hence, JTEC's Capex-to-Revenue for the three months ended in Mar. 2024 was 0.00.


JTEC Capex-to-Revenue Historical Data

The historical data trend for JTEC's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JTEC Capex-to-Revenue Chart

JTEC Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Capex-to-Revenue
Get a 7-Day Free Trial 0.57 0.26 - 0.10 0.04

JTEC Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of JTEC's Capex-to-Revenue

For the Medical Instruments & Supplies subindustry, JTEC's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JTEC's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, JTEC's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where JTEC's Capex-to-Revenue falls into.



JTEC Capex-to-Revenue Calculation

JTEC's Capex-to-Revenue for the fiscal year that ended in Jun. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-82.408) / 1908.375
=0.04

JTEC's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 265.842
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


JTEC  (TSE:3446) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


JTEC Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of JTEC's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


JTEC (TSE:3446) Business Description

Traded in Other Exchanges
N/A
Address
2-5-38 Saito-Yamabuki, Ibaraki-shi, Osaka, JPN, 567-0086
JTEC Corporation is engaged in developing, designing, manufacturing and sales of Automated Cell Culture System; X-ray Mirrors for Synchrotron Facilities; and Automated System in various fields. Its products in optical business include Kirkpatrick-Baez (KB) mirror, Advanced KB mirror (1D Wolter mirror), Montel mirror, Ellipsoidal mirror, 2D Walter mirror, Deformable mirror, Multi-channel mirror, X-ray focusing alignment system (JM1000 / 2000 series), Additional mirror shaping improvement, and Mirror coating. Its products in life science include CELLFLOAT products and Automated Cell Culture Systems.

JTEC (TSE:3446) Headlines

No Headlines